Corbin Capital Partners’s Alpha Tau Medical DRTS Stock Holding History

Corbin Capital Partners’s Portfolio DRTS Stock Details DRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-97,197	Closed	-$246K	–	31
2024 Q2	$246K	Sell	97,197 -162,912	-63%	-$414K	0.47%	14
2024 Q1	$760K	Hold	260,109	–	–	1.28%	12
2023 Q4	$783K	Hold	260,109	–	–	3.27%	7
2023 Q3	$986K	Hold	260,109	–	–	1.46%	10
2023 Q2	$1.14M	Buy	+260,109	New	+$932K	0.96%	19

Other funds holding DRTS

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

SAM

Satovsky Asset Management New York $566M AUM 15.8% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ACA

Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return

Corbin Capital Partners's DRTS Position: Q3 2024 in Review

Corbin Capital Partners sold out of Alpha Tau Medical (DRTS) in Q3 2024, closing a stake of 97,197 shares — an estimated $246K sold.

Corbin Capital Partners first reported a position in DRTS in Q2 2023 and held it in 5 quarters. The position peaked at $1.14M in Q2 2023. 23 funds tracked by Wall St. Rank hold DRTS as of Q3 2024.

Corbin Capital Partners reported no remaining Alpha Tau Medical position as of Q3 2024 after selling out during the quarter.
Corbin Capital Partners sold 97,197 Alpha Tau Medical shares in Q3 2024, an estimated $246K.
Corbin Capital Partners first reported a position in Alpha Tau Medical in Q2 2023 and held it in 5 quarters.
Corbin Capital Partners's Alpha Tau Medical position peaked at $1.14M in Q2 2023.
23 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q3 2024.

Based on Corbin Capital Partners's 13F filing for Q3 2024, filed 12 Nov 2024.